ArticleInternational journal of hematology2020
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
Shinichiro Matsuda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it